This is a Validated Antibody Database (VAD) review about dogs CLDN4, based on 146 published articles (read how Labome selects the articles), using CLDN4 antibody in all methods. It is aimed to help Labome visitors find the most suited CLDN4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Invitrogen
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s5f
  • immunohistochemistry - paraffin section; human; fig 5h
Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunohistochemistry - paraffin section on mouse samples (fig s5f) and in immunohistochemistry - paraffin section on human samples (fig 5h). Sci Adv (2022) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; 1:5000; loading ...; fig 6b
Invitrogen CLDN4 antibody (Thermofisher, 329400) was used in western blot on human samples at 1:5000 (fig 6b). Commun Biol (2021) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; dogs; loading ...; fig s2
  • western blot; dogs; loading ...; fig 3j
Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on dogs samples (fig s2) and in western blot on dogs samples (fig 3j). J Exp Clin Cancer Res (2021) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; 1:100; loading ...; fig s7c
Invitrogen CLDN4 antibody (Thermo Fisher Scientific, 32-9400) was used in immunocytochemistry on human samples at 1:100 (fig s7c). Proc Natl Acad Sci U S A (2021) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; 1:200; loading ...; fig 3c
Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunohistochemistry on human samples at 1:200 (fig 3c). Science (2020) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; dogs; fig 1
  • western blot; dogs; fig 1
In order to study the role of claudin-4 in tight junctions in MDCK cells, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on dogs samples (fig 1) and in western blot on dogs samples (fig 1). PLoS ONE (2017) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; dogs; 1.2 ug/ml; fig 4e
  • western blot; dogs; fig 2
In order to examine tight junction and adherence junction protein expression in the colorectal epithelium of dogs with inflammatory colorectal polyps, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on dogs samples at 1.2 ug/ml (fig 4e) and in western blot on dogs samples (fig 2). J Vet Med Sci (2017) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; domestic rabbit; 1:50; loading ...; fig 6a
In order to investigate the role of TRPV4 in a corneal epithelial cell model, Invitrogen CLDN4 antibody (Thermo Fisher, 32-9400) was used in immunocytochemistry on domestic rabbit samples at 1:50 (fig 6a). J Cell Physiol (2017) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; 1:700; fig 1b
In order to demonstrate that epidermal equivalents of filaggrin null keratinocytes do not have impaired skin barrier function, Invitrogen CLDN4 antibody (Thermo Fisher Scientific, 3E2C1) was used in immunocytochemistry on human samples at 1:700 (fig 1b). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; dogs; 1:200; tbl 5
In order to establish canine mammary tissue derived cell lines and study claudin expression, Invitrogen CLDN4 antibody (Thermo Fischer, 3E2C1) was used in immunocytochemistry on dogs samples at 1:200 (tbl 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 2c
  • western blot; dogs; 1:500; loading ...; fig 1g
In order to measure tight junction protein expression in canine duodenum, lung, liver, and kidney, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 2c) and in western blot on dogs samples at 1:500 (fig 1g). Mol Med Rep (2016) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; fig 1
  • western blot; human; fig 1
In order to examine tight junction function in atopic dermatitis samples, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunohistochemistry - paraffin section on human samples (fig 1) and in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; dogs; 1:200; fig 5
  • western blot; dogs; 1:1000; fig 3a
In order to investigate how serine proteases increase transepithelial electrical resistance, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on dogs samples at 1:200 (fig 5) and in western blot on dogs samples at 1:1000 (fig 3a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
mouse monoclonal (3E2C1)
  • western blot; mouse; 1:1000; loading ...; fig 3e
In order to evaluate the effect of glucocorticoids in a mouse model of colitis, Invitrogen CLDN4 antibody (Thermo Fisher, 32-9400) was used in western blot on mouse samples at 1:1000 (fig 3e). Biochem Pharmacol (2016) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; rat; 1:50; fig 4
  • western blot; rat; 1:500; fig 2
In order to analyze hyperoxia-induced pulmonary epithelial barrier breakdown and how caveolin-1 regulates the expression of tight junction proteins, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on rat samples at 1:50 (fig 4) and in western blot on rat samples at 1:500 (fig 2). Respir Res (2016) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; fig 5
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in western blot on human samples (fig 5). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (3E2C1)
  • western blot; pigs ; 1:1000; fig 7
In order to study a natural polyphenolic compound, resveratrol, and its protective capacity against deoxynivalenol-induced bacterial translocation and intestinal barrier dysfunction, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in western blot on pigs samples at 1:1000 (fig 7). Chem Res Toxicol (2016) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; fig 2
In order to characterize barrier breakdown and MAPK/NF-kappaB mediated stress response in the intestinal epithelial cell line C2BBe1 due to Candida albicans infection, Invitrogen CLDN4 antibody (Life Technologies, 3E2C1) was used in western blot on human samples (fig 2). Cell Microbiol (2016) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; 1:50
  • western blot; human; fig 2a
In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples (fig 2a). Exp Cell Res (2015) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; 0.5 ug/ml
In order to test if claudin 3 plays an instigating and/or a functional role in the urothelial tight junctions, Invitrogen CLDN4 antibody (Life Technologies, 3E2C1) was used in western blot on human samples at 0.5 ug/ml. Bladder (San Franc) (2015) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; rat
In order to study the mechanism of paclitaxel-induced lung injury and how parecoxib sodium suppresses injury, Invitrogen CLDN4 antibody (Invitrogen, 329400) was used in immunohistochemistry on rat samples . Sci Rep (2015) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 2
In order to evaluate the use of e-cadherin as a biomarker for medullary carcinoma, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Hum Pathol (2015) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; 1:167
In order to investigate the contribution of claudin-3 to breast cancer, Invitrogen CLDN4 antibody (Life Technologies, 32-9400) was used in western blot on human samples at 1:167. Oncol Lett (2015) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; rat; 1:100; fig 2
  • western blot; rat; 1:1000; fig 2
In order to elucidate ketamine-induced ulcerative cystitis and bladder apoptosis in association with oxidative stress mediated by mitochondria and the endoplasmic reticulum, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunohistochemistry on rat samples at 1:100 (fig 2) and in western blot on rat samples at 1:1000 (fig 2). Am J Physiol Renal Physiol (2015) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; rat; 1:500; loading ...; fig 3
In order to propose that claudin-4 is required for mAChR-modulated paracellular permeability of epithelial cells and investigate the mechanism, Invitrogen CLDN4 antibody (Life Technologies, 329494) was used in immunocytochemistry on rat samples at 1:500 (fig 3). J Cell Sci (2015) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; fig 3
In order to analyze the contribution of genetic alterations and cell type of origin in breast cancer phenotypes, Invitrogen CLDN4 antibody (Invitrogen, 329400) was used in immunohistochemistry on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; dogs; fig 6
  • western blot; dogs; fig 3
In order to identify the members of the tight junction proteome, Invitrogen CLDN4 antibody (Life Technologies, 32?C9488) was used in immunocytochemistry on dogs samples (fig 6) and in western blot on dogs samples (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; dogs
  • western blot; dogs
In order to characterize TALEN-mediated claudin-2 knockout in MDCK cells, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on dogs samples and in western blot on dogs samples . PLoS ONE (2015) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human
  • western blot; human
In order to investigate the effect of homoharringtonine on intestinal epithelial permeability and its mechanism, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on human samples and in western blot on human samples . Eur J Pharm Biopharm (2015) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; mouse; 1:500; fig 3
In order to study the contribution of ZO-1, -2, and -3 on collecting duct cell proliferation, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on mouse samples at 1:500 (fig 3). Cell Cycle (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human
In order to elucidate the relationship between DeltaNp63 and barrier function, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in immunohistochemistry - paraffin section on human samples . Biochem Biophys Res Commun (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to characterize claudin-4, CAIX and GLUT-1 in distant breast cancer metastases, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunohistochemistry - paraffin section on human samples at 1:100. BMC Cancer (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; Xenopus laevis; fig 3
In order to investigate matrix metalloproteinase expression in the Xenopus laevis corneal epithelium, Invitrogen CLDN4 antibody (Invitrogen, 329400) was used in immunohistochemistry - frozen section on Xenopus laevis samples (fig 3). PLoS ONE (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; 1:50; fig 1
In order to correlate expression of claudins with clinical outcomes of triple-negative breast cancer, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples at 1:50 (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (3E2C1)
  • western blot; human
In order to study tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in western blot on human samples . Surg Obes Relat Dis (2015) ncbi
mouse monoclonal (3E2C1)
  • western blot; domestic sheep; 1:500
In order to study the effect of a high-concentrate diet on colonic epithelial barrier and cell apoptosis in lactating goats, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in western blot on domestic sheep samples at 1:500. BMC Vet Res (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human
  • western blot; human; 1:500
Invitrogen CLDN4 antibody (Zymed Laboratories, 3E2C1) was used in immunohistochemistry on human samples and in western blot on human samples at 1:500. Adv Biomed Res (2014) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; fig 5
In order to develop a method for universal conjugation of antibodies to lipid-coated nanoparticles using radially oriented FcgammaRIs, Invitrogen CLDN4 antibody (Invitrogen, 329400) was used in immunocytochemistry on human samples (fig 5). Bioconjug Chem (2014) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; dogs
  • western blot; dogs
In order to characterize the TALEN-mediated ZO-1 knockout in MDCK cells, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on dogs samples and in western blot on dogs samples . PLoS ONE (2014) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human
In order to examine the effect of CD137 on epithelial cell function, Invitrogen CLDN4 antibody (Life Technologies, 329400) was used in immunocytochemistry on human samples . Physiol Rep (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1d
In order to correlate claudin 1-5 and 7 expression with the survival, grade, and stage of patients with renal cell cancer, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 1d). Anticancer Res (2014) ncbi
mouse monoclonal (3E2C1)
  • western blot; dogs; fig 1
In order to measure the expression of tight junction and adherens junction proteins in duodenal mucosa samples of dogs with inflammatory bowel disease, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in western blot on dogs samples (fig 1). Am J Vet Res (2014) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; 1:100; fig 4
  • immunocytochemistry; dogs; 1:100; fig 4
In order to assess the contribution of enteropathogenic Escherichia coli EspG-mediated microtubule disruption to tight junction perturbation, Invitrogen CLDN4 antibody (Life Technologies, 329400) was used in immunocytochemistry on human samples at 1:100 (fig 4) and in immunocytochemistry on dogs samples at 1:100 (fig 4). Cell Microbiol (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:250
Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:250. Hum Pathol (2014) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; rat; 1:200
  • western blot; rat; 1:400
In order to study hepatocyte polarity and various claudins that are expressed in tight junctions of cell lines, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunocytochemistry on rat samples at 1:200 and in western blot on rat samples at 1:400. Tissue Barriers (2013) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2
In order to compare tricellulin expression in normal and cirrhotic liver with that of primary hepatic neoplasms, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2). Pathol Oncol Res (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human
In order to enhance our understanding of Brca2, Pten and p53 in breast cancer development, Invitrogen CLDN4 antibody (Invitrogen-Life, 3E2C1) was used in immunohistochemistry on human samples . J Pathol (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; fig 6
In order to examine zeb1, twist, and claudins 1 and 4 in normal and diseased placental tissues, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 6). APMIS (2014) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; mouse; 1:100; fig 1
  • western blot; mouse; 1:500; fig 1
In order to study the role of Cldn6 in epithelial differentiation, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on mouse samples at 1:100 (fig 1) and in western blot on mouse samples at 1:500 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; fig 2
In order to develop a universal interface system composed of protein G and 6xHis-tag and use it to identify a pancreatic cancer biomarker, Invitrogen CLDN4 antibody (Invitrogen, 329400) was used in immunocytochemistry on human samples (fig 2). ACS Nano (2013) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; 1:1000
In order to investigate the regulation of ZO-1 by p38delta mitogen-activated protein kinase in differentiating human epidermal keratinocytes, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in western blot on human samples at 1:1000. Arch Dermatol Res (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to investigate the prognostic significance of claudin-4 in gastric cancer, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). World J Surg Oncol (2013) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; 1:100; fig 2
  • immunohistochemistry; human; 1:100; fig 1
In order to report that tight junctions are physiological regulated by sex hormones during the menstrual cycle, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in immunohistochemistry on human samples at 1:100 (fig 1). Cell Tissue Res (2013) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; fig 11
In order to develop an in vitro model of gelatinous drop-like corneal dystrophy using a new cell line deficient in tumor-associated calcium signal transducer 2, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in western blot on human samples (fig 11). Trans Am Ophthalmol Soc (2012) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 10 ug/ml
In order to study the role of Nrf2 in the maintenance of murine esophageal epithelial barrier function, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunohistochemistry - paraffin section on human samples at 10 ug/ml. Gut (2014) ncbi
mouse monoclonal (3E2C1)
  • western blot; mouse; 1:250
In order to evaluate an in vitro model of blood brain barrier, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in western blot on mouse samples at 1:250. PLoS ONE (2013) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; fig 6
In order to examine the structure-activity relationship for N-alkyl-N-quaternary chitosan derivatives used as permeation enhancers for drugs, Invitrogen CLDN4 antibody (Life Technologies, 329400) was used in western blot on human samples (fig 6). Eur J Pharm Biopharm (2014) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human
In order to investigate the thymus development, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples . Development (2013) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; 1:200; fig S8
  • immunohistochemistry; human; 1:2000; fig S4
In order to identify elements of intestinal polarity regulated by Rab25, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on human samples at 1:200 (fig S8) and in immunohistochemistry on human samples at 1:2000 (fig S4). Mol Biol Cell (2013) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to examine tight junction and adherens junction proteins in normal human lung, IPF, cryptogenic organizing pneumonia, and asbestosis, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Hum Pathol (2013) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; fig s10
In order to identify genetic variants associated with pancreatitis, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in western blot on human samples (fig s10). Nat Genet (2012) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; fig 2
In order to investigate the assembly and disassembly of tricellular in tight junctions by altering the calcium concentration, Invitrogen CLDN4 antibody (Zymed Laboratories, 3E2C1) was used in immunocytochemistry on human samples (fig 2). Cell Tissue Res (2013) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; fig 4
In order to use a novel cell-based model system to study phenotypic plasticity in triple-negative breast cancer, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in western blot on human samples (fig 4). PLoS ONE (2012) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; pigs ; loading ...; fig 2a
  • western blot; pigs ; 1:250; loading ...
In order to compare the intestinal toxicity of deoxynivalenol and acetylated deoxynivalenol, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunocytochemistry on pigs samples (fig 2a) and in western blot on pigs samples at 1:250. Toxicol Sci (2012) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; fig 2
In order to test if GLP-2 regulates tight junctions, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in western blot on human samples (fig 2). Regul Pept (2012) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; fig 4
In order to examine the role of Twist1 in the regulation of claudin-4 expression using human esophageal carcinoma cell lines, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 4). Biochem Biophys Res Commun (2012) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 2
In order to develop and characterize a model for Hailey-Hailey disease using normal keratinocytes, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 2). Exp Dermatol (2012) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; human; 1:100
  • western blot; human; 1:1000; fig 2
In order to assess the role of tight junctions and gap proteins in cervical remodeling, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry - frozen section on human samples at 1:100 and in western blot on human samples at 1:1000 (fig 2). J Transl Med (2012) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; dogs; fig 1
  • western blot; dogs; fig 2, 4
In order to examine the effect of treating epithelial cells with an inhibitor of the lipid kinase PIKfyve, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunocytochemistry on dogs samples (fig 1) and in western blot on dogs samples (fig 2, 4). PLoS ONE (2012) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; mouse; 1:75; fig 1
In order to study lymphoid neogenesis and tertiary lymphoid organs in pigs with leptospiral nephritis, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in immunohistochemistry - paraffin section on mouse samples at 1:75 (fig 1). Vet Immunol Immunopathol (2012) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:50; fig 2
In order to ascertain the expression of claudin 1, 3M, 3S, 4, 5, and 7 in vulvar epithelial neoplasia and compare their expression in samples with invasive vulvar squamous cell carcinoma, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2). Tumour Biol (2012) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; fig 1
In order to assess the changes in claudins function via PKCalpha activation in pancreatic cancer cells, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in western blot on human samples (fig 1). Cell Tissue Res (2011) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; dogs; loading ...; fig s1a
In order to investigate the effect of ouabain on cilia development in epithelial cells, Invitrogen CLDN4 antibody (Invitrogen, 32-9400) was used in immunocytochemistry on dogs samples (fig s1a). Proc Natl Acad Sci U S A (2011) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; 1:200; fig 1
In order to establish and characterize a cell line derived from an endocervical tissue explant, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunocytochemistry on human samples at 1:200 (fig 1). J Reprod Immunol (2011) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 2
In order to study three clinical cases of follicular dendritic cell sarcoma, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Hum Pathol (2012) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; fig 7
In order to discuss the use of ex vivo organ culture systems to study viral infections, Invitrogen CLDN4 antibody (Zymed Laboratories, 3E2C1) was used in immunohistochemistry on human samples (fig 7). PLoS ONE (2011) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; 1:25; fig s7
In order to demonstrate that ESCRT proteins are required to maintain polarity in mammalian epithelial cells, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunocytochemistry on human samples at 1:25 (fig s7). Mol Biol Cell (2011) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; fig 4
In order to examine the responses to Clostridium perfringens enterotoxin via claudin-4 in normal human pancreatic duct epithelial cells, Invitrogen CLDN4 antibody (Zymed Laboratories, clone 3E2C1) was used in immunocytochemistry on human samples (fig 4). Cell Mol Biol Lett (2011) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 0.25 ug/ml; loading ...; fig 2a
  • immunocytochemistry; human; 0.25 ug/ml; loading ...; fig 7b
  • western blot; human; loading ...; fig 7a
In order to test if claudin 4 expression is associated with the outcome of ovarian cancer patients, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 0.25 ug/ml (fig 2a), in immunocytochemistry on human samples at 0.25 ug/ml (fig 7b) and in western blot on human samples (fig 7a). Int J Mol Sci (2011) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; pigs ; 1:50; loading ...; fig 4
In order to compare the effects of prolonged minimized and conventional cardiopulmonary bypass on intestinal mucosal integrity, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on pigs samples at 1:50 (fig 4). Scand Cardiovasc J (2011) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; 1:100; loading ...; fig 1a
In order to assess the use of Claudin 4 expression in the detection of metastatic tumor cells and in differentiating reactive and neoplastic mesothelium, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples at 1:100 (fig 1a). Diagn Cytopathol (2011) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; fig 5
In order to characterize a graft source from human salivary glands, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry on human samples (fig 5). Tissue Eng Part A (2011) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; pigs ; 1:100; fig 3
  • western blot; pigs ; 1:500; fig 3
In order to test the involvement of mitogen-activated protein kinases in the deoxynivalenol-induced loss of barrier function, Invitrogen CLDN4 antibody (Zymed Laboratories, 3E2C1) was used in immunocytochemistry on pigs samples at 1:100 (fig 3) and in western blot on pigs samples at 1:500 (fig 3). J Nutr (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to examine the prognostic significance of claudin-4 expression in esophageal squamous cell carcinoma, Invitrogen CLDN4 antibody (Zymed, clone 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Ann Surg Oncol (2011) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3
In order to report the expression of claudins 1, 3-7 and transcriptional factor twist in testicular germ cell tumors, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 3). APMIS (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; 1:25
In order to determine the activation profile of EGFR, PDGFRB, and PDGFRA receptors and their downstream effectors in diffuse malignant peritoneal mesothelioma specimens, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples at 1:25. Eur J Cancer (2010) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; fig 5
  • immunohistochemistry; human; fig 2
  • western blot; human; fig 2
In order to determine the relationship between the TACSTD2 gene and epithelial barrier function, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunocytochemistry on human samples (fig 5), in immunohistochemistry on human samples (fig 2) and in western blot on human samples (fig 2). Am J Pathol (2010) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; fig 4
In order to study the impact of somatostatin and its receptors in the skin, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in western blot on human samples (fig 4). Exp Dermatol (2010) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; 1:100; loading ...; fig 3a
  • western blot; human; 1:1000; loading ...; fig 2c
In order to examine the expression of tight junction proteins in normal human pancreatic duct epithelial cells, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunocytochemistry on human samples at 1:100 (fig 3a) and in western blot on human samples at 1:1000 (fig 2c). Am J Pathol (2010) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; 1:1000; fig 4
In order to test if the c-Jun N-terminal kinase pathway regulates tricellulin, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in western blot on human samples at 1:1000 (fig 4). J Cell Physiol (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1d
In order to measure claudins 1, 3, 4, 5, and 7 expression in developing human lung tissues during gestation, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 1d). Respir Res (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; 1:100; tbl 2
In order to examine the expression of claudins in patients with nasopharyngeal carcinoma, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples at 1:100 (tbl 2). Hum Pathol (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; loading ...; fig 3a
  • western blot; human; loading ...; fig 3b
In order to test if impaired recognition of muramyldipeptide via NOD2 variants is associated with increased bacterial translocation and alterations in NF-kappaB activation, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples (fig 3a) and in western blot on human samples (fig 3b). Inflamm Bowel Dis (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; fig 3
In order to determine claudin expression profiles in Epstein-Barr virus-associated non-keratinizing nasopharyngeal carcinoma, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 3). Oncol Rep (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; fig 4
In order to study claudin tight junction proteins and differential expression in the human cortical nephron, Invitrogen CLDN4 antibody (Invitrogen, noca) was used in immunohistochemistry on human samples (fig 4). Nephrol Dial Transplant (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; 1:100; loading ...
In order to study the presence of dendritic cells expressing autoimmune regulator in peripheral lymphoid tissue in humans, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples at 1:100. Am J Pathol (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; 1:100; fig 4
In order to determine the expression and localization of tricellulin, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples at 1:100 (fig 4). Med Mol Morphol (2009) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; human; 1:100
In order to examine tight junction protein expression in venous leg ulcers, Invitrogen CLDN4 antibody (Zymed Laboratories, 32-9400) was used in immunohistochemistry - frozen section on human samples at 1:100. Clin Exp Dermatol (2009) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; rat; 5 ug/ml
  • western blot; rat; 2 ug/ml
In order to examine the cellular distributions of tight junction components during early pregnancy and under various hormonal regimens, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry - frozen section on rat samples at 5 ug/ml and in western blot on rat samples at 2 ug/ml. Acta Histochem (2010) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:400
In order to characterize 6 cases of biliary neoplasms, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:400. Hum Pathol (2009) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; fig 3
In order to examine iron-associated toxicity in intestinal epithelial cells, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunocytochemistry on human samples (fig 3). Toxicol In Vitro (2009) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; pigs ; 1:100
  • immunocytochemistry; pigs ; fig 3
  • western blot; pigs ; fig 3
  • immunocytochemistry; human; 1:100; fig 3
  • western blot; human; 1:500; fig 3
In order to examine the effects of deoxynivalenol on the intestinal epithelium, Invitrogen CLDN4 antibody (Zymed Laboratories, 3E2C1) was used in immunohistochemistry - paraffin section on pigs samples at 1:100, in immunocytochemistry on pigs samples (fig 3), in western blot on pigs samples (fig 3), in immunocytochemistry on human samples at 1:100 (fig 3) and in western blot on human samples at 1:500 (fig 3). Toxicol Appl Pharmacol (2009) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; human; 1:100; fig 1
In order to study the expression of adherens junction and tight junction components in human peripheral nerve endoneurium, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 1). J Histochem Cytochem (2009) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 1c
  • western blot; human; 1:1000; fig 1a
In order to examine the distribution and potential clinical value of claudin-4 in breast cancer, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1c) and in western blot on human samples at 1:1000 (fig 1a). Int J Cancer (2009) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
In order to determine the expression of several different claudins in rectal well-differentiated endocrine neoplasms, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Oncol Rep (2009) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 3
In order to investigate the changes of global gene expression in lobular carcinoma in situ, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). Breast Cancer Res (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 3
In order to study the production CXCL13 by follicular dendritic cells and its utility as a marker of follicular dendritic cell sarcoma, Invitrogen CLDN4 antibody (Invitrogen, clone 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). J Pathol (2008) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 1
In order to suggest that aPKC regulates tight junction formation through the phosphorylation of claudin-4, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 1). Exp Cell Res (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; fig 1
In order to test if altered expression of intestinal epithelial tight junction proteins contributes to neoplastic progression, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Lab Invest (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2a
In order to study translocation of HIV across the vaginal pluristratified epithelium, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 2a). AIDS (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
In order to analyze claudin 1, 4, 5, and 7 and occludin expression in the superficial and invasive front of squamous cell carcinoma of the tongue and correlate with disease outcome, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Hum Pathol (2008) ncbi
mouse monoclonal (3E2C1)
  • western blot; southern flounder; 1:500; fig 1c
In order to elucidate acclimation of southern flounder to changes in salinity, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in western blot on southern flounder samples at 1:500 (fig 1c). Comp Biochem Physiol A Mol Integr Physiol (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; loading ...; fig 1f
In order to report the case of a 65-year-old man with a colonic adenocarcinoma and a single small liver nodule, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples (fig 1f). Int J Surg Pathol (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1c
In order to study M cells in the epithelial barrier of the human adenoid, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - frozen section on mouse samples (fig 1c). J Mol Histol (2008) ncbi
mouse monoclonal (3E2C1)
  • western blot; Tilapia; 1:500; fig 1
In order to assess the regulation of tight-junctional claudins during salinity acclimation in fish, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in western blot on Tilapia samples at 1:500 (fig 1). Am J Physiol Regul Integr Comp Physiol (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3b
In order to identify predictors for lymph node metastasis in patients with early colorectal cancer, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3b). Cancer (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; loading ...; fig 2d
In order to measure expression of claudins in prostate adenocarcinoma and compare their expression to that of non-neoplastic epithelium and correlate expression with the Gleason score of the tumors, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples (fig 2d). Oncol Rep (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 10 ug/ml; tbl 1
In order to define the localization of CD81, scavenger receptor class B member I, and Claudin-1 in HCV entry of hepatocytes, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 10 ug/ml (tbl 1). Hepatology (2008) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1b
In order to measure expression of occludin and claudin-1, -4, and -7 in thyroid neoplasms, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 1b). Mod Pathol (2008) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; 1:2000; fig 8
In order to find phospho-p38 MAPK level significantly increases in poorly differentiated gastric cancers compared to differentiated cancers and normal gastric mucosa, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in western blot on human samples at 1:2000 (fig 8). Pathol Int (2007) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; 1:50; fig 2
In order to determine gene expression of claudin 3 and claudin 4 in ovarian carcinomas and ovarian serous tumors, Invitrogen CLDN4 antibody (Zymed Laboratories, 3E2C1) was used in immunohistochemistry on human samples at 1:50 (fig 2). Histol Histopathol (2007) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1d
In order to identify immunohistochemical expression patterns of claudin 1 and claudin 4 in recurrent and non-recurrent breast cancer groups, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1d). Int J Mol Med (2007) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; fig 1
In order to measure the expression of tight junction proteins in human lung squamous cell carcinomas and adenocarcinomas, Invitrogen CLDN4 antibody (Invitrogen, 3E2C1) was used in immunohistochemistry on human samples (fig 1). Mod Pathol (2007) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1 ug/ml; fig 1
  • immunocytochemistry; human; 2 ug/ml; fig 7
  • western blot; human; 0.5 ug/ml; fig 6B
In order to ask if urothelial differentiation failure contributes to the aetiopathology of interstitial cystitis, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry - paraffin section on human samples at 1 ug/ml (fig 1), in immunocytochemistry on human samples at 2 ug/ml (fig 7) and in western blot on human samples at 0.5 ug/ml (fig 6B). BJU Int (2007) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; human; fig 1
In order to review structural proteins of epidermal tight junctions, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry - frozen section on human samples (fig 1). Br J Dermatol (2007) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1c
In order to assess expression of claudins 1, 4, 5, and 7 in ovarian lesions, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Int J Gynecol Pathol (2006) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry; human; loading ...; fig 2b
In order to demonstrate that tight junctions join medullary stromal cells of the human thymus, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry on human samples (fig 2b). J Histochem Cytochem (2006) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; fig 1a
  • immunocytochemistry; human; fig 4b
  • western blot; human; fig 3a
In order to investigate the expression and regulation of tight junction proteins in human urothelium, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 1a), in immunocytochemistry on human samples (fig 4b) and in western blot on human samples (fig 3a). J Cell Physiol (2006) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; human; 1:167
  • western blot; human
In order to examine the molecular composition of the tight junction present in human term placenta from normal women and from those with preeclampsia, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry - frozen section on human samples at 1:167 and in western blot on human samples . Cell Tissue Res (2006) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:50
In order to observe the expression of claudins in mesothelioma and metastatic pleural adenocarcinoma, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:50. J Clin Pathol (2006) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; fig 2
In order to determine the expression of claudin-4 in the biliary tree, biliary tract cancers, and hepatocellular carcinomas, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry - paraffin section on human samples (fig 2). Mod Pathol (2006) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; 1:250; fig 1A
In order to investigate tight junction alterations in adenocarcinoma tissues, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in western blot on human samples at 1:250 (fig 1A). FEBS Lett (2005) ncbi
mouse monoclonal (3E2C1)
  • western blot; human; 1:1000; fig 3
In order to investigate the mechanisms that regulate IFN-gamma-mediated barrier disruption, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in western blot on human samples at 1:1000 (fig 3). Clin Exp Immunol (2005) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2c
In order to correlate claudins 1, 3, 4, and 5 expression with proliferation, apoptosis, and E-cadherin expression in gastric carcinoma samples, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 2c). Virchows Arch (2006) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; pigs ; 1:100
In order to characterize a permanent porcine intestinal epithelial cell line to use as an in vitro infection model, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunocytochemistry on pigs samples at 1:100. Histochem Cell Biol (2006) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to test if the expression pattern of claudins 1, 3, and 4 as well as ZO-1 in patients with gastric cancer correlate with the clinicopathologic and prognostic variables, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). Hum Pathol (2005) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human
In order to study the formation of fluid-filled hemicysts called domes by epithelial cells, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunocytochemistry on human samples . J Biol Chem (2005) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
In order to measure and compare claudin 2, 3, 4, and 5 expression in patients with Paget's disease with those of other neoplastic skin lesions, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Hum Pathol (2004) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; human; 1:100; fig 2
In order to examine the expression and function of tight junctions in the epithelium of human palatine tonsils from patients with tonsillar hypertrophy or recurrent tonsillitis, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2). J Histochem Cytochem (2004) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to evaluate the effect of three different fixation methods on pathology samples, Invitrogen CLDN4 antibody (Zymed, 329400) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Diagn Mol Pathol (2004) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to investigate the pattern of expression and prognostic value of claudin-1, claudin-4, occludin, and ZO-1 in a cohort of TNM stage II colon cancer, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). Mod Pathol (2005) ncbi
mouse monoclonal (3E2C1)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 5
In order to investigate the effects of estrogen on transcervical tight-junctional resistance, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 5). J Clin Endocrinol Metab (2004) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - frozen section; human
In order to discuss tight junction abnormalities and claudin-1 involvement in tumors of simple epithelia, Invitrogen CLDN4 antibody (Zymed, 32-9400) was used in immunohistochemistry - frozen section on human samples . Br J Dermatol (2004) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
In order to measure claudin 4 protein expression in patients with primary infiltrating pancreatic cancer, patients with metastatic pancreatic cancer, and a panel of normal control tissue samples, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 2). Am J Clin Pathol (2004) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; 1:400; fig 5F
In order to examine the gene expression profiles of intraductal papillary mucinous neoplasms, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 5F). Am J Pathol (2004) ncbi
mouse monoclonal (3E2C1)
  • immunohistochemistry - paraffin section; human; fig 5
In order to examine the changes in gene expression during the transition between the early luteal and mid-luteal phases in human endometrium, Invitrogen CLDN4 antibody (Zymed, 3E2C1) was used in immunohistochemistry - paraffin section on human samples (fig 5). Mol Hum Reprod (2002) ncbi
Articles Reviewed
  1. Werder R, Liu T, Abo K, Lindstrom Vautrin J, Villacorta Martin C, Huang J, et al. CRISPR interference interrogation of COPD GWAS genes reveals the functional significance of desmoplakin in iPSC-derived alveolar epithelial cells. Sci Adv. 2022;8:eabo6566 pubmed publisher
  2. Tabariès S, Annis M, Lazaris A, Petrillo S, Huxham J, Abdellatif A, et al. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern. Commun Biol. 2021;4:657 pubmed publisher
  3. Kumar B, Ahmad R, Giannico G, Zent R, Talmon G, Harris R, et al. Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation. J Exp Clin Cancer Res. 2021;40:77 pubmed publisher
  4. Wijshake T, Zou Z, Chen B, Zhong L, Xiao G, Xie Y, et al. Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  5. Pellegrini L, Bonfio C, Chadwick J, Begum F, Skehel M, Lancaster M. Human CNS barrier-forming organoids with cerebrospinal fluid production. Science. 2020;: pubmed publisher
  6. Tokuda S, Hirai T, Furuse M. Claudin-4 knockout by TALEN-mediated gene targeting in MDCK cells: Claudin-4 is dispensable for the permeability properties of tight junctions in wild-type MDCK cells. PLoS ONE. 2017;12:e0182521 pubmed publisher
  7. Yokoyama N, Ohta H, Kagawa Y, Leela Arporn R, Dermlim A, Nisa K, et al. Expression of apical junction complex proteins in colorectal mucosa of miniature dachshunds with inflammatory colorectal polyps. J Vet Med Sci. 2017;79:456-463 pubmed publisher
  8. Martínez Rendón J, Sánchez Guzmán E, Rueda A, González J, Gulias Cañizo R, Aquino Jarquin G, et al. TRPV4 Regulates Tight Junctions and Affects Differentiation in a Cell Culture Model of the Corneal Epithelium. J Cell Physiol. 2017;232:1794-1807 pubmed publisher
  9. Niehues H, Schalkwijk J, van Vlijmen Willems I, Rodijk Olthuis D, van Rossum M, Wladykowski E, et al. Epidermal equivalents of filaggrin null keratinocytes do not show impaired skin barrier function. J Allergy Clin Immunol. 2017;139:1979-1981.e13 pubmed publisher
  10. Hammer S, Becker A, Rateitschak K, Mohr A, Lüder Ripoli F, Hennecke S, et al. Longitudinal Claudin Gene Expression Analyses in Canine Mammary Tissues and Thereof Derived Primary Cultures and Cell Lines. Int J Mol Sci. 2016;17: pubmed
  11. Ahn C, Shin D, Lee D, Kang S, Seok J, Kang H, et al. Expression of claudins, occludin, junction adhesion molecule A and zona occludens 1 in canine organs. Mol Med Rep. 2016;14:3697-703 pubmed publisher
  12. Yuki T, Tobiishi M, Kusaka Kikushima A, Ota Y, Tokura Y. Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17. PLoS ONE. 2016;11:e0161759 pubmed publisher
  13. Ronaghan N, Shang J, Iablokov V, Zaheer R, Colarusso P, Dion S, et al. The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction. Am J Physiol Gastrointest Liver Physiol. 2016;311:G466-79 pubmed publisher
  14. Ocón B, Aranda C, Gámez Belmonte R, Suárez M, Zarzuelo A, Martinez Augustin O, et al. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice. Biochem Pharmacol. 2016;116:73-88 pubmed publisher
  15. Xu S, Xue X, You K, Fu J. Caveolin-1 regulates the expression of tight junction proteins during hyperoxia-induced pulmonary epithelial barrier breakdown. Respir Res. 2016;17:50 pubmed publisher
  16. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  17. Ling K, Wan M, El Nezami H, Wang M. Protective Capacity of Resveratrol, a Natural Polyphenolic Compound, against Deoxynivalenol-Induced Intestinal Barrier Dysfunction and Bacterial Translocation. Chem Res Toxicol. 2016;29:823-33 pubmed publisher
  18. Böhringer M, Pohlers S, Schulze S, Albrecht Eckardt D, Piegsa J, Weber M, et al. Candida albicans infection leads to barrier breakdown and a MAPK/NF-κB mediated stress response in the intestinal epithelial cell line C2BBe1. Cell Microbiol. 2016;18:889-904 pubmed publisher
  19. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
  20. Smith N, Hinley J, Varley C, Eardley I, Trejdosiewicz L, Southgate J. The human urothelial tight junction: claudin 3 and the ZO-1α+ switch. Bladder (San Franc). 2015;2:e9 pubmed
  21. Liu W, Zhong Z, Cao L, Li H, Zhang T, Lin W. Paclitaxel-induced lung injury and its amelioration by parecoxib sodium. Sci Rep. 2015;5:12977 pubmed publisher
  22. Takahashi S, Kohashi K, Yamamoto H, Hirahashi M, Kumagai R, Takizawa N, et al. Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum. Hum Pathol. 2015;46:1257-66 pubmed publisher
  23. Todd M, Petty H, King J, Piana Marshall B, Sheller R, Cuevas M. Overexpression and delocalization of claudin-3 protein in MCF-7 and MDA-MB-415 breast cancer cell lines. Oncol Lett. 2015;10:156-162 pubmed
  24. Liu K, Chuang S, Long C, Lee Y, Wang C, Lu M, et al. Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum. Am J Physiol Renal Physiol. 2015;309:F318-31 pubmed publisher
  25. Cong X, Zhang Y, Li J, Mei M, Ding C, Xiang R, et al. Claudin-4 is required for modulation of paracellular permeability by muscarinic acetylcholine receptor in epithelial cells. J Cell Sci. 2015;128:2271-86 pubmed publisher
  26. Bhagirath D, Zhao X, West W, Qiu F, Band H, Band V. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes. Oncotarget. 2015;6:9018-30 pubmed
  27. Fredriksson K, Van Itallie C, Aponte A, Gucek M, Tietgens A, Anderson J. Proteomic analysis of proteins surrounding occludin and claudin-4 reveals their proximity to signaling and trafficking networks. PLoS ONE. 2015;10:e0117074 pubmed publisher
  28. Tokuda S, Furuse M. Claudin-2 knockout by TALEN-mediated gene targeting in MDCK cells: claudin-2 independently determines the leaky property of tight junctions in MDCK cells. PLoS ONE. 2015;10:e0119869 pubmed publisher
  29. Watari A, Hashegawa M, Yagi K, Kondoh M. Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers. Eur J Pharm Biopharm. 2015;89:232-8 pubmed publisher
  30. Qiao X, Roth I, Féraille E, Hasler U. Different effects of ZO-1, ZO-2 and ZO-3 silencing on kidney collecting duct principal cell proliferation and adhesion. Cell Cycle. 2014;13:3059-75 pubmed publisher
  31. Kubo T, Sugimoto K, Kojima T, Sawada N, Sato N, Ichimiya S. Tight junction protein claudin-4 is modulated via ΔNp63 in human keratinocytes. Biochem Biophys Res Commun. 2014;455:205-11 pubmed publisher
  32. Jiwa L, van Diest P, Hoefnagel L, Wesseling J, Wesseling P, Moelans C. Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases. BMC Cancer. 2014;14:864 pubmed publisher
  33. Wiechmann A, Ceresa B, Howard E. Diurnal variation of tight junction integrity associates inversely with matrix metalloproteinase expression in Xenopus laevis corneal epithelium: implications for circadian regulation of homeostatic surface cell desquamation. PLoS ONE. 2014;9:e113810 pubmed publisher
  34. Ma F, Ding X, Fan Y, Ying J, Zheng S, Lu N, et al. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer. PLoS ONE. 2014;9:e112765 pubmed publisher
  35. Casselbrant A, Elias E, Fändriks L, Wallenius V. Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2015;11:45-53 pubmed publisher
  36. Tao S, Duanmu Y, Dong H, Tian J, Ni Y, Zhao R. A high-concentrate diet induced colonic epithelial barrier disruption is associated with the activating of cell apoptosis in lactating goats. BMC Vet Res. 2014;10:235 pubmed publisher
  37. Afshar Moghaddam N, Heidarpour M, Dashti S. Diagnostic value of claudin-4 marker in pleural and peritoneal effusion cytology: Does it differentiate between metastatic adenocarcinoma and reactive mesothelial cells?. Adv Biomed Res. 2014;3:161 pubmed publisher
  38. Kim C, Galloway J, Lee K, Searson P. Universal antibody conjugation to nanoparticles using the Fcγ receptor I (FcγRI): quantitative profiling of membrane biomarkers. Bioconjug Chem. 2014;25:1893-901 pubmed publisher
  39. Tokuda S, Higashi T, Furuse M. ZO-1 knockout by TALEN-mediated gene targeting in MDCK cells: involvement of ZO-1 in the regulation of cytoskeleton and cell shape. PLoS ONE. 2014;9:e104994 pubmed publisher
  40. Gusti V, Bennett K, Lo D. CD137 signaling enhances tight junction resistance in intestinal epithelial cells. Physiol Rep. 2014;2: pubmed publisher
  41. Virman J, Soini Y, Kujala P, Luukkaala T, Salminen T, Sunela K, et al. Claudins as prognostic factors for renal cell cancer. Anticancer Res. 2014;34:4181-7 pubmed
  42. Ohta H, Sunden Y, Yokoyama N, Osuga T, Lim S, Tamura Y, et al. Expression of apical junction complex proteins in duodenal mucosa of dogs with inflammatory bowel disease. Am J Vet Res. 2014;75:746-51 pubmed publisher
  43. Glotfelty L, Zahs A, Hodges K, Shan K, Alto N, Hecht G. Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration. Cell Microbiol. 2014;16:1767-83 pubmed publisher
  44. Ordonez N, Sahin A. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study. Hum Pathol. 2014;45:1529-40 pubmed publisher
  45. Grosse B, Degrouard J, Jaillard D, Cassio D. Build them up and break them down: Tight junctions of cell lines expressing typical hepatocyte polarity with a varied repertoire of claudins. Tissue Barriers. 2013;1:e25210 pubmed publisher
  46. Somorácz A, Korompay A, Törzsök P, Patonai A, Erdélyi Belle B, Lotz G, et al. Tricellulin expression and its prognostic significance in primary liver carcinomas. Pathol Oncol Res. 2014;20:755-64 pubmed publisher
  47. Melchor L, Molyneux G, Mackay A, Magnay F, Atienza M, Kendrick H, et al. Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models. J Pathol. 2014;233:124-37 pubmed publisher
  48. Pirinen E, Soini Y. A survey of zeb1, twist and claudin 1 and 4 expression during placental development and disease. APMIS. 2014;122:530-8 pubmed publisher
  49. Sugimoto K, Ichikawa Tomikawa N, Satohisa S, Akashi Y, Kanai R, Saito T, et al. The tight-junction protein claudin-6 induces epithelial differentiation from mouse F9 and embryonic stem cells. PLoS ONE. 2013;8:e75106 pubmed publisher
  50. Hwang M, Lee J, Lee K, Lee K. Think modular: a simple apoferritin-based platform for the multifaceted detection of pancreatic cancer. ACS Nano. 2013;7:8167-74 pubmed publisher
  51. Siljamäki E, Raiko L, Toriseva M, Nissinen L, Näreoja T, Peltonen J, et al. p38? mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes. Arch Dermatol Res. 2014;306:131-41 pubmed publisher
  52. Zhu J, Gao P, Wang Z, Song Y, Li A, Xu Y, et al. Clinicopathological significance of claudin-4 in gastric carcinoma. World J Surg Oncol. 2013;11:150 pubmed publisher
  53. Someya M, Kojima T, Ogawa M, Ninomiya T, Nomura K, Takasawa A, et al. Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano. Cell Tissue Res. 2013;354:481-94 pubmed publisher
  54. Kinoshita S, Kawasaki S, Kitazawa K, Shinomiya K. Establishment of a human conjunctival epithelial cell line lacking the functional TACSTD2 gene (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2012;110:166-77 pubmed
  55. Chen H, Hu Y, Fang Y, Djukic Z, Yamamoto M, Shaheen N, et al. Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium. Gut. 2014;63:711-9 pubmed publisher
  56. Díaz Coránguez M, Segovia J, López Ornelas A, Puerta Guardo H, Ludert J, Chávez B, et al. Transmigration of neural stem cells across the blood brain barrier induced by glioma cells. PLoS ONE. 2013;8:e60655 pubmed publisher
  57. Benediktsdóttir B, Gudjonsson T, Baldursson O, Másson M. N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. Eur J Pharm Biopharm. 2014;86:55-63 pubmed publisher
  58. Farley A, Morris L, Vroegindeweij E, Depreter M, Vaidya H, Stenhouse F, et al. Dynamics of thymus organogenesis and colonization in early human development. Development. 2013;140:2015-26 pubmed publisher
  59. Krishnan M, Lapierre L, Knowles B, Goldenring J. Rab25 regulates integrin expression in polarized colonic epithelial cells. Mol Biol Cell. 2013;24:818-31 pubmed publisher
  60. Lappi Blanco E, Lehtonen S, Sormunen R, Merikallio H, Soini Y, Kaarteenaho R. Divergence of tight and adherens junction factors in alveolar epithelium in pulmonary fibrosis. Hum Pathol. 2013;44:895-907 pubmed publisher
  61. Whitcomb D, Larusch J, Krasinskas A, Klei L, Smith J, Brand R, et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet. 2012;44:1349-54 pubmed publisher
  62. Takasawa A, Kojima T, Ninomiya T, Tsujiwaki M, Murata M, Tanaka S, et al. Behavior of tricellulin during destruction and formation of tight junctions under various extracellular calcium conditions. Cell Tissue Res. 2013;351:73-84 pubmed publisher
  63. D Amato N, OSTRANDER J, Bowie M, Sistrunk C, Borowsky A, Cardiff R, et al. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. PLoS ONE. 2012;7:e45684 pubmed publisher
  64. Pinton P, Tsybulskyy D, Lucioli J, Laffitte J, Callu P, Lyazhri F, et al. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases. Toxicol Sci. 2012;130:180-90 pubmed publisher
  65. Moran G, O NEILL C, McLaughlin J. GLP-2 enhances barrier formation and attenuates TNF?-induced changes in a Caco-2 cell model of the intestinal barrier. Regul Pept. 2012;178:95-101 pubmed publisher
  66. Lee K, Lee N, Kim J, Kang M, Yoo H, Kim H, et al. Twist1 causes the transcriptional repression of claudin-4 with prognostic significance in esophageal cancer. Biochem Biophys Res Commun. 2012;423:454-60 pubmed publisher
  67. Raiko L, Siljamäki E, Mahoney M, Putaala H, Suominen E, Peltonen J, et al. Hailey-Hailey disease and tight junctions: Claudins 1 and 4 are regulated by ATP2C1 gene encoding Ca(2+) /Mn(2+) ATPase SPCA1 in cultured keratinocytes. Exp Dermatol. 2012;21:586-91 pubmed publisher
  68. Ghule V, Gray C, Galimberti A, Anumba D. Prostaglandin-induced cervical remodelling in humans in the first trimester is associated with increased expression of specific tight junction, but not gap junction proteins. J Transl Med. 2012;10:40 pubmed publisher
  69. Dukes J, Whitley P, Chalmers A. The PIKfyve inhibitor YM201636 blocks the continuous recycling of the tight junction proteins claudin-1 and claudin-2 in MDCK cells. PLoS ONE. 2012;7:e28659 pubmed publisher
  70. Pezzolato M, Maina E, Lonardi S, Bozzetta E, Grassi F, Scanziani E, et al. Development of tertiary lymphoid structures in the kidneys of pigs with chronic leptospiral nephritis. Vet Immunol Immunopathol. 2012;145:546-50 pubmed publisher
  71. Riski M, Santala M, Soini Y, Talvensaari Mattila A. Claudins 1, 3M, 3S, 4, 5 and 7 in vulvar neoplasms compared with vulvar squamous cell carcinoma. Tumour Biol. 2012;33:537-42 pubmed publisher
  72. Kyuno D, Kojima T, Ito T, Yamaguchi H, Tsujiwaki M, Takasawa A, et al. Protein kinase C? inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. Cell Tissue Res. 2011;346:369-81 pubmed publisher
  73. Larre I, Castillo A, Flores Maldonado C, Contreras R, Galván I, Muñoz Estrada J, et al. Ouabain modulates ciliogenesis in epithelial cells. Proc Natl Acad Sci U S A. 2011;108:20591-6 pubmed publisher
  74. Buckner L, Schust D, Ding J, Nagamatsu T, Beatty W, Chang T, et al. Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix. J Reprod Immunol. 2011;92:8-20 pubmed publisher
  75. Lorenzi L, Lonardi S, Petrilli G, Tanda F, Bella M, Laurino L, et al. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders. Hum Pathol. 2012;43:209-15 pubmed publisher
  76. Horbul J, Schmechel S, Miller B, Rice S, Southern P. Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture. PLoS ONE. 2011;6:e22638 pubmed publisher
  77. Dukes J, Fish L, Richardson J, Blaikley E, Burns S, Caunt C, et al. Functional ESCRT machinery is required for constitutive recycling of claudin-1 and maintenance of polarity in vertebrate epithelial cells. Mol Biol Cell. 2011;22:3192-205 pubmed publisher
  78. Yamaguchi H, Kojima T, Ito T, Kyuno D, Kimura Y, Imamura M, et al. Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells. Cell Mol Biol Lett. 2011;16:385-97 pubmed publisher
  79. Boylan K, Misemer B, De Rycke M, Andersen J, Harrington K, Kalloger S, et al. Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation. Int J Mol Sci. 2011;12:1334-58 pubmed publisher
  80. Rimpiläinen R, Vakkala M, Rimpiläinen E, Jensen H, Rimpiläinen J, Erkinaro T, et al. Minimized and conventional cardiopulmonary bypass damage intestinal mucosal integrity. Scand Cardiovasc J. 2011;45:236-46 pubmed publisher
  81. Lonardi S, Manera C, Marucci R, Santoro A, Lorenzi L, Facchetti F. Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions. Diagn Cytopathol. 2011;39:313-7 pubmed publisher
  82. Maria O, Zeitouni A, Gologan O, Tran S. Matrigel improves functional properties of primary human salivary gland cells. Tissue Eng Part A. 2011;17:1229-38 pubmed publisher
  83. Pinton P, Braicu C, Nougayrede J, Laffitte J, Taranu I, Oswald I. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism. J Nutr. 2010;140:1956-62 pubmed publisher
  84. Sung C, Han S, Kim S. Low expression of claudin-4 is associated with poor prognosis in esophageal squamous cell carcinoma. Ann Surg Oncol. 2011;18:273-81 pubmed publisher
  85. Väre P, Soini Y. Twist is inversely associated with claudins in germ cell tumors of the testis. APMIS. 2010;118:640-7 pubmed publisher
  86. Perrone F, Jocollè G, Pennati M, Deraco M, Baratti D, Brich S, et al. Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma. Eur J Cancer. 2010;46:2837-48 pubmed publisher
  87. Nakatsukasa M, Kawasaki S, Yamasaki K, Fukuoka H, Matsuda A, Tsujikawa M, et al. Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am J Pathol. 2010;177:1344-55 pubmed publisher
  88. Vockel M, Breitenbach U, Kreienkamp H, Brandner J. Somatostatin regulates tight junction function and composition in human keratinocytes. Exp Dermatol. 2010;19:888-94 pubmed publisher
  89. Yamaguchi H, Kojima T, Ito T, Kimura Y, Imamura M, Son S, et al. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells. Am J Pathol. 2010;177:698-712 pubmed publisher
  90. Kojima T, Fuchimoto J, Yamaguchi H, Ito T, Takasawa A, Ninomiya T, et al. c-Jun N-terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells. J Cell Physiol. 2010;225:720-33 pubmed publisher
  91. Kaarteenaho R, Merikallio H, Lehtonen S, Harju T, Soini Y. Divergent expression of claudin -1, -3, -4, -5 and -7 in developing human lung. Respir Res. 2010;11:59 pubmed publisher
  92. Hsueh C, Chang Y, Tseng N, Liao C, Hsueh S, Chang J, et al. Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma. Hum Pathol. 2010;41:944-50 pubmed publisher
  93. Kosovac K, Brenmoehl J, Holler E, Falk W, Schoelmerich J, Hausmann M, et al. Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients. Inflamm Bowel Dis. 2010;16:1311-21 pubmed publisher
  94. Kojima F, Ishida M, Takikita Suzuki M, Hotta M, Katsura K, Nagata A, et al. Claudin expression profiles in Epstein-Barr virus-associated nasopharyngeal carcinoma. Oncol Rep. 2010;23:927-31 pubmed
  95. Kirk A, Campbell S, Bass P, Mason J, Collins J. Differential expression of claudin tight junction proteins in the human cortical nephron. Nephrol Dial Transplant. 2010;25:2107-19 pubmed publisher
  96. Poliani P, Kisand K, Marrella V, Ravanini M, Notarangelo L, Villa A, et al. Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells. Am J Pathol. 2010;176:1104-12 pubmed publisher
  97. Ohkuni T, Kojima T, Ogasawara N, Masaki T, Ninomiya T, Kikuchi S, et al. Expression and localization of tricellulin in human nasal epithelial cells in vivo and in vitro. Med Mol Morphol. 2009;42:204-11 pubmed publisher
  98. Zorko M, Veranic P, Leskovec N, Pavlovic M, Lunder T. Expression of tight-junction proteins in the inflamed and clinically uninvolved skin in patients with venous leg ulcers. Clin Exp Dermatol. 2009;34:e949-52 pubmed publisher
  99. Nicholson M, Lindsay L, Murphy C. Ovarian hormones control the changing expression of claudins and occludin in rat uterine epithelial cells during early pregnancy. Acta Histochem. 2010;112:42-52 pubmed publisher
  100. Tanaka M, Fukushima N, Noda N, Shibahara J, Kokudo N, Fukayama M. Intraductal oncocytic papillary neoplasm of the bile duct: clinicopathologic and immunohistochemical characteristics of 6 cases. Hum Pathol. 2009;40:1543-52 pubmed publisher
  101. Natoli M, Felsani A, Ferruzza S, Sambuy Y, Canali R, Scarino M. Mechanisms of defence from Fe(II) toxicity in human intestinal Caco-2 cells. Toxicol In Vitro. 2009;23:1510-5 pubmed publisher
  102. Pinton P, Nougayrede J, del Rio J, Moreno C, Marin D, Ferrier L, et al. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol. 2009;237:41-8 pubmed publisher
  103. Alanne M, Pummi K, Heape A, Grenman R, Peltonen J, Peltonen S. Tight junction proteins in human Schwann cell autotypic junctions. J Histochem Cytochem. 2009;57:523-9 pubmed publisher
  104. Lanigan F, McKiernan E, Brennan D, Hegarty S, Millikan R, McBryan J, et al. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer. 2009;124:2088-97 pubmed publisher
  105. Ishida M, Kushima R, Okabe H. Claudin expression in rectal well-differentiated endocrine neoplasms (carcinoid tumors). Oncol Rep. 2009;21:113-7 pubmed
  106. Cao D, Polyak K, Halushka M, Nassar H, Kouprina N, Iacobuzio Donahue C, et al. Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9. Breast Cancer Res. 2008;10:R91 pubmed publisher
  107. Vermi W, Lonardi S, Bosisio D, Uguccioni M, Danelon G, Pileri S, et al. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma. J Pathol. 2008;216:356-64 pubmed publisher
  108. Aono S, Hirai Y. Phosphorylation of claudin-4 is required for tight junction formation in a human keratinocyte cell line. Exp Cell Res. 2008;314:3326-39 pubmed publisher
  109. Weber C, Nalle S, Tretiakova M, Rubin D, Turner J. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88:1110-20 pubmed publisher
  110. Bouschbacher M, Bomsel M, Verronèse E, Gofflo S, Ganor Y, Dezutter Dambuyant C, et al. Early events in HIV transmission through a human reconstructed vaginal mucosa. AIDS. 2008;22:1257-66 pubmed publisher
  111. Bello I, Vilen S, Niinimaa A, Kantola S, Soini Y, Salo T. Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum Pathol. 2008;39:1212-20 pubmed publisher
  112. Tipsmark C, Luckenbach J, Madsen S, Kiilerich P, Borski R. Osmoregulation and expression of ion transport proteins and putative claudins in the gill of southern flounder (Paralichthys lethostigma). Comp Biochem Physiol A Mol Integr Physiol. 2008;150:265-73 pubmed publisher
  113. Gambarotti M, Medicina D, Baronchelli C, Bercich L, Bonetti F, Facchetti F. Alpha-1-antitrypsin-positive "signet-ring" bile duct adenoma in a patient with M(MALTON) mutation. Int J Surg Pathol. 2008;16:218-21 pubmed publisher
  114. Takano K, Kojima T, Ogasawara N, Go M, Kikuchi S, Ninomiya T, et al. Expression of tight junction proteins in epithelium including Ck20-positive M-like cells of human adenoids in vivo and in vitro. J Mol Histol. 2008;39:265-73 pubmed publisher
  115. Tipsmark C, Baltzegar D, Ozden O, Grubb B, Borski R. Salinity regulates claudin mRNA and protein expression in the teleost gill. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1004-14 pubmed publisher
  116. Ishikawa Y, Akishima Fukasawa Y, Ito K, Akasaka Y, Yokoo T, Ishii T. Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. Cancer. 2008;112:924-33 pubmed publisher
  117. Väre P, Loikkanen I, Hirvikoski P, Vaarala M, Soini Y. Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma. Oncol Rep. 2008;19:25-31 pubmed
  118. Reynolds G, Harris H, Jennings A, Hu K, Grove J, Lalor P, et al. Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology. 2008;47:418-27 pubmed
  119. Tzelepi V, Tsamandas A, Vlotinou H, Vagianos C, Scopa C. Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms. Mod Pathol. 2008;21:22-30 pubmed
  120. Atsumi T, Kato K, Uno K, Iijima K, Koike T, Imatani A, et al. Pathophysiological role of the activation of p38 mitogen-activated protein kinases in poorly differentiated gastric cancer. Pathol Int. 2007;57:635-44 pubmed
  121. Choi Y, Kim J, Kwon M, Choi J, Kim T, Bae D, et al. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation. Histol Histopathol. 2007;22:1185-95 pubmed publisher
  122. Morohashi S, Kusumi T, Sato F, Odagiri H, Chiba H, Yoshihara S, et al. Decreased expression of claudin-1 correlates with recurrence status in breast cancer. Int J Mol Med. 2007;20:139-43 pubmed
  123. Paschoud S, Bongiovanni M, Pache J, Citi S. Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod Pathol. 2007;20:947-54 pubmed
  124. Southgate J, Varley C, Garthwaite M, Hinley J, Marsh F, Stahlschmidt J, et al. Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int. 2007;99:1506-16 pubmed
  125. Peltonen S, Riehokainen J, Pummi K, Peltonen J. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis. Br J Dermatol. 2007;156:466-72 pubmed
  126. Soini Y, Talvensaari Mattila A. Expression of claudins 1, 4, 5, and 7 in ovarian tumors of diverse types. Int J Gynecol Pathol. 2006;25:330-5 pubmed
  127. Ichimiya S, Kojima T. Cellular networks of human thymic medullary stromas coordinated by p53-related transcription factors. J Histochem Cytochem. 2006;54:1277-89 pubmed
  128. Varley C, Garthwaite M, Cross W, Hinley J, Trejdosiewicz L, Southgate J. PPARgamma-regulated tight junction development during human urothelial cytodifferentiation. J Cell Physiol. 2006;208:407-17 pubmed
  129. Liévano S, Alarcón L, Chavez Munguia B, Gonzalez Mariscal L. Endothelia of term human placentae display diminished expression of tight junction proteins during preeclampsia. Cell Tissue Res. 2006;324:433-48 pubmed
  130. Soini Y, Kinnula V, Kahlos K, Paakko P. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol. 2006;59:250-4 pubmed
  131. Lódi C, Szabó E, Holczbauer A, Batmunkh E, Szijarto A, Kupcsulik P, et al. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol. 2006;19:460-9 pubmed
  132. de Oliveira S, de Oliveira I, de Souza W, Morgado Diaz J. Claudins upregulation in human colorectal cancer. FEBS Lett. 2005;579:6179-85 pubmed
  133. Willemsen L, Hoetjes J, van Deventer S, van Tol E. Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition. Clin Exp Immunol. 2005;142:275-84 pubmed
  134. Soini Y, Tommola S, Helin H, Martikainen P. Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch. 2006;448:52-8 pubmed
  135. Schierack P, Nordhoff M, Pollmann M, Weyrauch K, Amasheh S, Lodemann U, et al. Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesis in swine. Histochem Cell Biol. 2006;125:293-305 pubmed
  136. Resnick M, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt D, et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol. 2005;36:886-92 pubmed
  137. Shlyonsky V, Goolaerts A, Van Beneden R, Sariban Sohraby S. Differentiation of epithelial Na+ channel function. An in vitro model. J Biol Chem. 2005;280:24181-7 pubmed
  138. Soini Y. Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma. Hum Pathol. 2004;35:1531-6 pubmed
  139. Go M, Kojima T, Takano K, Murata M, Ichimiya S, Tsubota H, et al. Expression and function of tight junctions in the crypt epithelium of human palatine tonsils. J Histochem Cytochem. 2004;52:1627-38 pubmed
  140. Páska C, Bögi K, Szilak L, Tokés A, Szabó E, Sziller I, et al. Effect of formalin, acetone, and RNAlater fixatives on tissue preservation and different size amplicons by real-time PCR from paraffin-embedded tissue. Diagn Mol Pathol. 2004;13:234-40 pubmed
  141. Resnick M, Konkin T, Routhier J, Sabo E, Pricolo V. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol. 2005;18:511-8 pubmed
  142. Zeng R, Li X, Gorodeski G. Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation. J Clin Endocrinol Metab. 2004;89:5145-55 pubmed
  143. Morita K, Tsukita S, Miyachi Y. Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease. Br J Dermatol. 2004;151:328-34 pubmed
  144. Nichols L, Ashfaq R, Iacobuzio Donahue C. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol. 2004;121:226-30 pubmed
  145. Sato N, Fukushima N, Maitra A, Iacobuzio Donahue C, Van Heek N, Cameron J, et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol. 2004;164:903-14 pubmed
  146. Carson D, Lagow E, Thathiah A, Al Shami R, Farach Carson M, Vernon M, et al. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod. 2002;8:871-9 pubmed